Clinical Guidance Category

Present On Admission Exempt Codes

ICD-10-CM diagnosis codes exempt from POA reporting based on the official FY2026 CMS POA exempt list.

Linked Diagnostic CodesPage 273 of 384 (38,349 total)
  • T45.612DBillable

    Poisoning by thrombolytic drug, intentional self-harm, subsequent encounter

  • T45.612SBillable

    Poisoning by thrombolytic drug, intentional self-harm, sequela

  • T45.613DBillable

    Poisoning by thrombolytic drug, assault, subsequent encounter

  • T45.613SBillable

    Poisoning by thrombolytic drug, assault, sequela

  • T45.614DBillable

    Poisoning by thrombolytic drug, undetermined, subsequent encounter

  • T45.614SBillable

    Poisoning by thrombolytic drug, undetermined, sequela

  • T45.615DBillable

    Adverse effect of thrombolytic drugs, subsequent encounter

  • T45.615SBillable

    Adverse effect of thrombolytic drugs, sequela

  • T45.616DBillable

    Underdosing of thrombolytic drugs, subsequent encounter

  • T45.616SBillable

    Underdosing of thrombolytic drugs, sequela

  • T45.621DBillable

    Poisoning by hemostatic drug, accidental (unintentional), subsequent encounter

  • T45.621SBillable

    Poisoning by hemostatic drug, accidental (unintentional), sequela

  • T45.622DBillable

    Poisoning by hemostatic drug, intentional self-harm, subsequent encounter

  • T45.622SBillable

    Poisoning by hemostatic drug, intentional self-harm, sequela

  • T45.623DBillable

    Poisoning by hemostatic drug, assault, subsequent encounter

  • T45.623SBillable

    Poisoning by hemostatic drug, assault, sequela

  • T45.624DBillable

    Poisoning by hemostatic drug, undetermined, subsequent encounter

  • T45.624SBillable

    Poisoning by hemostatic drug, undetermined, sequela

  • T45.625DBillable

    Adverse effect of hemostatic drug, subsequent encounter

  • T45.625SBillable

    Adverse effect of hemostatic drug, sequela

  • T45.626DBillable

    Underdosing of hemostatic drugs, subsequent encounter

  • T45.626SBillable

    Underdosing of hemostatic drugs, sequela

  • T45.691DBillable

    Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter

  • T45.691SBillable

    Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), sequela

  • T45.692DBillable

    Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter

  • T45.692SBillable

    Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, sequela

  • T45.693DBillable

    Poisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter

  • T45.693SBillable

    Poisoning by other fibrinolysis-affecting drugs, assault, sequela

  • T45.694DBillable

    Poisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter

  • T45.694SBillable

    Poisoning by other fibrinolysis-affecting drugs, undetermined, sequela

  • T45.695DBillable

    Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter

  • T45.695SBillable

    Adverse effect of other fibrinolysis-affecting drugs, sequela

  • T45.696DBillable

    Underdosing of other fibrinolysis-affecting drugs, subsequent encounter

  • T45.696SBillable

    Underdosing of other fibrinolysis-affecting drugs, sequela

  • T45.7X1DBillable

    Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter

  • T45.7X1SBillable

    Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), sequela

  • T45.7X2DBillable

    Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter

  • T45.7X2SBillable

    Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela

  • T45.7X3DBillable

    Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter

  • T45.7X3SBillable

    Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela

  • T45.7X4DBillable

    Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter

  • T45.7X4SBillable

    Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela

  • T45.7X5DBillable

    Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter

  • T45.7X5SBillable

    Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela

  • T45.7X6DBillable

    Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter

  • T45.7X6SBillable

    Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela

  • T45.8X1DBillable

    Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter

  • T45.8X1SBillable

    Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela

  • T45.8X2DBillable

    Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter

  • T45.8X2SBillable

    Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela

  • T45.8X3DBillable

    Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter

  • T45.8X3SBillable

    Poisoning by other primarily systemic and hematological agents, assault, sequela

  • T45.8X4DBillable

    Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter

  • T45.8X4SBillable

    Poisoning by other primarily systemic and hematological agents, undetermined, sequela

  • T45.8X5DBillable

    Adverse effect of other primarily systemic and hematological agents, subsequent encounter

  • T45.8X5SBillable

    Adverse effect of other primarily systemic and hematological agents, sequela

  • T45.8X6DBillable

    Underdosing of other primarily systemic and hematological agents, subsequent encounter

  • T45.8X6SBillable

    Underdosing of other primarily systemic and hematological agents, sequela

  • T45.91XDBillable

    Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter

  • T45.91XSBillable

    Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela

  • T45.92XDBillable

    Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter

  • T45.92XSBillable

    Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela

  • T45.93XDBillable

    Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter

  • T45.93XSBillable

    Poisoning by unspecified primarily systemic and hematological agent, assault, sequela

  • T45.94XDBillable

    Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter

  • T45.94XSBillable

    Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela

  • T45.95XDBillable

    Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter

  • T45.95XSBillable

    Adverse effect of unspecified primarily systemic and hematological agent, sequela

  • T45.96XDBillable

    Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter

  • T45.96XSBillable

    Underdosing of unspecified primarily systemic and hematological agent, sequela

  • T45.AX1DBillable

    Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter

  • T45.AX1SBillable

    Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela

  • T45.AX2DBillable

    Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter

  • T45.AX2SBillable

    Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela

  • T45.AX3DBillable

    Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter

  • T45.AX3SBillable

    Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela

  • T45.AX4DBillable

    Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter

  • T45.AX4SBillable

    Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequela

  • T45.AX5DBillable

    Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter

  • T45.AX5SBillable

    Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela

  • T45.AX6DBillable

    Underdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter

  • T45.AX6SBillable

    Underdosing of immune checkpoint inhibitors and immunostimulant drugs, sequela

  • T46.0X1DBillable

    Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter

  • T46.0X1SBillable

    Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela

  • T46.0X2DBillable

    Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter

  • T46.0X2SBillable

    Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela

  • T46.0X3DBillable

    Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter

  • T46.0X3SBillable

    Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela

  • T46.0X4DBillable

    Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter

  • T46.0X4SBillable

    Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela

  • T46.0X5DBillable

    Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter

  • T46.0X5SBillable

    Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela

  • T46.0X6DBillable

    Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter

  • T46.0X6SBillable

    Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela

  • T46.1X1DBillable

    Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter

  • T46.1X1SBillable

    Poisoning by calcium-channel blockers, accidental (unintentional), sequela

  • T46.1X2DBillable

    Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter

  • T46.1X2SBillable

    Poisoning by calcium-channel blockers, intentional self-harm, sequela

  • T46.1X3DBillable

    Poisoning by calcium-channel blockers, assault, subsequent encounter

  • T46.1X3SBillable

    Poisoning by calcium-channel blockers, assault, sequela